Vir Biotechnology, Inc.
VIR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$522 | -$615 | $516 | $529 |
| Dep. & Amort. | $15 | $19 | $7 | $6 |
| Deferred Tax | -$3 | -$1 | -$15 | $15 |
| Stock-Based Comp. | $78 | $0 | $102 | $84 |
| Change in WC | -$84 | -$305 | $665 | -$628 |
| Other Non-Cash | $70 | $122 | $388 | -$53 |
| Operating Cash Flow | -$446 | -$779 | $1,663 | -$48 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$7 | -$22 | -$68 | -$22 |
| Net Acquisitions | $3 | $0 | $0 | $141 |
| Inv. Purchases | -$1,235 | -$2,016 | -$1,477 | -$420 |
| Inv. Sales/Matur. | $1,739 | $2,202 | $352 | $301 |
| Other Inv. Act. | $0 | $0 | $0 | -$141 |
| Investing Cash Flow | $499 | $165 | -$1,193 | -$141 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$0 | -$0 | -$0 | -$0 |
| Stock Issued | $5 | $8 | $28 | $85 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$0 | $7 | $15 |
| Financing Cash Flow | $4 | $7 | $35 | $100 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $57 | -$606 | $505 | -$88 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $261 | $861 | $363 | $451 |
| End Cash | $319 | $255 | $868 | $363 |
| Free Cash Flow | -$454 | -$800 | $1,595 | -$69 |